Predictive Oncology Price to Free Cash Flow Ratio 2010-2024 | POAI
Historical price to free cash flow ratio values for Predictive Oncology (POAI) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Predictive Oncology Price to Free Cash Flow Ratio Historical Data |
| Date |
Stock Price |
TTM FCF per Share |
Price to FCF Ratio |
| 2025-05-09 |
1.11 |
|
0.00 |
| 2024-12-31 |
0.82 |
$-2.01 |
0.00 |
| 2024-09-30 |
0.79 |
$-2.08 |
0.00 |
| 2024-06-30 |
1.04 |
$-2.54 |
0.00 |
| 2024-03-31 |
2.55 |
$-2.91 |
0.00 |
| 2023-12-31 |
3.29 |
$-2.94 |
0.00 |
| 2023-09-30 |
3.20 |
$-3.30 |
0.00 |
| 2023-06-30 |
4.86 |
$-3.44 |
0.00 |
| 2023-03-31 |
6.54 |
$-3.39 |
0.00 |
| 2022-12-31 |
6.14 |
$-3.47 |
0.00 |
| 2022-09-30 |
7.20 |
$-4.40 |
0.00 |
| 2022-06-30 |
8.20 |
$-4.26 |
0.00 |
| 2022-03-31 |
19.54 |
$-3.70 |
0.00 |
| 2021-12-31 |
19.04 |
$-4.78 |
0.00 |
| 2021-09-30 |
26.60 |
$-10.28 |
0.00 |
| 2021-06-30 |
26.20 |
$-9.68 |
0.00 |
| 2021-03-31 |
24.20 |
$-10.51 |
0.00 |
| 2020-12-31 |
14.64 |
$-20.69 |
0.00 |
| 2020-09-30 |
16.28 |
$-36.38 |
0.00 |
| 2020-06-30 |
32.80 |
$-60.82 |
0.00 |
| 2020-03-31 |
31.50 |
$-47.07 |
0.00 |
| 2019-12-31 |
52.20 |
$-60.89 |
0.00 |
| 2019-09-30 |
101.00 |
$-59.05 |
0.00 |
| 2019-06-30 |
149.60 |
$-44.25 |
0.00 |
| 2019-03-31 |
150.00 |
$-81.00 |
0.00 |
| 2018-12-31 |
123.80 |
$-85.29 |
0.00 |
| 2018-09-30 |
212.00 |
$-103.52 |
0.00 |
| 2018-06-30 |
226.00 |
$-127.70 |
0.00 |
| 2018-03-31 |
220.00 |
$-135.26 |
0.00 |
| 2017-12-31 |
202.00 |
$-141.60 |
0.00 |
| 2017-09-30 |
290.80 |
$-190.13 |
0.00 |
| 2017-06-30 |
294.00 |
$-173.11 |
0.00 |
| 2017-03-31 |
420.00 |
$94.03 |
4.47 |
| 2016-12-31 |
560.00 |
$-312.73 |
0.00 |
| 2016-09-30 |
825.00 |
$-243.74 |
0.00 |
| 2016-06-30 |
765.00 |
$-256.52 |
0.00 |
| 2016-03-31 |
865.00 |
$-492.01 |
0.00 |
| 2015-12-31 |
14700.00 |
$-48.56 |
0.00 |
| 2015-09-30 |
16070.00 |
$-29.56 |
0.00 |
| 2015-06-30 |
15500.00 |
$-0.55 |
0.00 |
| 2015-03-31 |
17250.00 |
$-0.55 |
0.00 |
| 2014-12-31 |
32500.00 |
$-1.16 |
0.00 |
| 2014-09-30 |
41250.00 |
$-1.21 |
0.00 |
| 2014-06-30 |
56250.00 |
$85.27 |
659.64 |
| 2014-03-31 |
69375.00 |
$41.00 |
1692.15 |
| 2013-12-31 |
101250.00 |
$-1.99 |
0.00 |
| 2013-09-30 |
119250.00 |
$-37.82 |
0.00 |
| 2013-06-30 |
56250.00 |
$-114.10 |
0.00 |
| 2013-03-31 |
53250.00 |
$-90.38 |
0.00 |
| 2012-12-31 |
45000.00 |
$-85.08 |
0.00 |
| 2012-09-30 |
28125.00 |
$-198.28 |
0.00 |
| 2012-06-30 |
24375.00 |
$-247.62 |
0.00 |
| 2012-03-31 |
18750.00 |
$-294.22 |
0.00 |
| 2011-12-31 |
105000.00 |
$-366.86 |
0.00 |
| 2011-09-30 |
131250.00 |
$-245.25 |
0.00 |
| 2011-06-30 |
33750.00 |
$-281.43 |
0.00 |
| 2011-03-31 |
36000.00 |
$-432.23 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Information Systems |
$0.010B |
$0.002B |
|
Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS.
|
